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ABSTRACT 
 A simple and efficient liquid chromatographic method has been developed and validated for the simultaneous 
determination of pseudoephedrine, dextromethorphan, and triprolidine in cough and cold syrup. The separation of the 
analytes was achieved within 10min, employing a mixture of 50% v/v methanol-water containing 35.07 mM/L ammonium 
acetate adjusted to pH 5.58 as isocratic mobile phase, pumped at 1.0 ml min
-1
 through a strong cation exchange column 
(10µm particle size). The analytes were detected at 265nm. Statistical experimental designs and graphic representations 
(response surface methodologies, Pareto charts) were used for optimizing the mobile phase composition. The linearity of 
the calibration (r>0.99, n =18) in the relevant ranges (up to 125% of the expected concentrations of the analytes in the 
formulation), method accuracy (RSD <2.0%), repeatability (RSD<2.0%) and intermediate precision, were verified. System 
suitability parameters were also determined. The validated method was successfully employed for the routine analysis of a 
syrup pharmaceutical preparation against cough and cold, showing satisfactory analytes recoveries and precsion. 
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1. INTRODUCTION 
Cough and cold medications usually contain a complex mixture of nitrogenous compounds as active ingredients. These 
are usually present in varying and very different proportions, have diverse properties inherent to their formulation and 
desired action, and often possess some similar physical and chemical properties, which turns their separation difficult. 
Moreover, in the case of HPLC analysis, these basic drugs strongly interact with the reversed-phase stationary materials, 
causing peak asymmetry and lowering separation efficiency [1]. Due to these characteristics, quality control of 
preparations against the cough and cold always offers an interesting analytical challenge [2].
 
 
Pseudoephedrine (PS), triprolidine  (TR), and dextromethorphan (DX) are nitrogenous compounds (Figure 1) widely used 
as active ingredients in combined cold medicine formulations due to their decongestant (PS), antihistaminic (TR) and 
cough suppressant (DX) activities [3]. Their commercial associations exhibit important mass differences among the 
analytes (PS:TR up to 24:1, w/w) , in addition being liquids common formulations of these products require addition of 
preservatives such as methylparaben (MP), prorylparaben (PP), or sodium benzoate (SB). All these aspects increase the 
analytical challenge. 
                          
            Dextromethorphan (DX)               Triprolidine (TR)                 Pseudoephedrine (PS) 
Fig 1: Chemical structures of dextromethorphan, triprolidine, and pseudoephedrine. 
The use of strong cation exchanger (SCX) materials, such as propylsulfonic acid, which are highly acidic (pKa ˂1) and 
effectively ionized at all pH values, makes the development of separations for basic compounds relatively straightforward, 
besides its other advantage related to its specificity for the analysis of basic compounds when present in mixture with 
acidic/neutral compounds as the latter are either not retained or poorly retained [4-6].
 
 
Literature survey revealed the interest in the determination of PS, TR, and DX in pharmaceutical formulations either alone
 
or in combination with other active principles [7-29]. The simultaneous analysis of the three components has been 
performed by a few methods only, including UV spectrophotometry [30-32] and HPLC [33]. 
The objective of the present work was to develop and validate a high-performance chromatographic methodology for the 
simultaneous determination of PS, DX, and TR in their combined syrup formulations, using cation-exchange stationary 
phase. Experimental design techniques as a rational, cost-effective and convenient tool to speed up the process were 
employed for development of the proposed method [34]. 
The novelty of the proposed method stems from its ability within a reasonable analysis time, to separate such a complex 
mixture without interference from the co-formulated additives and without prior sample pre-treatment. The cost 
effectiveness of the method in term of using inexpensive reagents and chemicals is another benefit added. 
DOI 10.24297/jac.v13i11.5911
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2. MATERIALS AND METHODS 
2.1 Apparatus and Software        
Experiments were performed on a Shimadzu Prominence HPLC system consisted of: degasser (Model DGU-20A5), pump 
(Model LC-20AD), Rheodyne manual injector fitted with 20 µl loop, variable wavelength UV–Vis detector (ModelSPD-20A). 
Experimental design, data analysis and desirability function calculations were performed by using Design-Expert
® 
trial 
version7.0.0. (Stat-Ease Inc., Minneapolis). Statistical analyses were carried using Microsoft Excel 2013 software 
(Microsoft, USA). 
2.2 Reagents and Materials  
Analytical grade reagents: ammonium acetate (E. Merck, Germany), glacial acetic acid  (Scharlau Chemie, Spain), HPLC-
grade methanol (Scharlau Chemie, Spain) and double-distilled water were employed for the preparation of the samples 
and for chromatographic analysis. 
Pseudoephedrine hydrochloride, dextromethorphan hydrobromide and triprolidine hydrochloride working standards 
(99.1%, 99.3 %, and 99.6%, respectively), were kindly provided by Amipharma Laboratories, Sudan. Unifed DM Syrup 
(Labeled to contain: Triprolidine HCl 1.25 mg, Pseudoephedrine HCl 30 mg and Dextromethorphan HBr 10 mg per each 5 
ml) was purchased from local market. 
2.3 Preparation of Solutions 
2.3.1 Optimization Standard 
One ml from a stock solution containing 1.3 mg/mL of triprolidine HCl  and 1.0 mg/mL of prorylparaben (PP) in methanol 
was transferred into a 20 ml volumetric flask containing accurately weighed about 35 mg pseudoephedrine HCl and 20 mg 
dextromethorphan HBr. To this mixture 10 mL of 50% v/v aqueous methanol diluent were added , content of the flask was 
sonicated for 5 minutes, cooled and made to mark using the same diluent.  
2.3.2 Stock standard solution 
Stock standard solution was prepared by initially dissolving accurately weighed about 180 mg pseudoephedrine HCl, 10 
mg triprolidine HCl and 60 mg dextromethorphan HBr in 20 mL volumetric flask using 10 mL of 50% v/v aqueous methanol 
diluent. The content of the flask was then sonicated for 5 minutes, cooled and adjusted to mark using the same diluent.  
Other standard solutions were prepared by proper dilution of aliquots from the stock standard solution with 50% v/v 
aqueous methanol. 
2.3.3 Working standard solution 
Working standard solution containing PS (1800 µg/mL), TR (100 µg/mL) and DX (600 µg/mL) was freshly prepared by 
diluting 10 ml of stock standard solutions to 50 ml with 50% aqueous methanol. 
2.3.4 Sample preparation 
The sample density was determined and then sample weight accurately equivalent to 5 mL was taken in 20 mL volumetric 
flask, 10 mL of 50% aqueous methanol diluent were added and sample was then sonicated for 5 minutes, cooled and 
made to mark using same diluent. The sample was filtered through 0.45 µm nylon filter and 20 µl were injected into the 
HPLC system. 
2.3.5 Chromatographic Procedure 
Chromatographic separations were carried out on a Partisil 10 SCX column (10 µm particle size, 250 mm×4.6 mm 
I.D.).During the optimization experiments the mobile phases were prepared to contain different proportions of methanol-
water-ammonium acetate, the pH of the mobile phases was adjusted with 10% glacial acetic acid. The detection 
wavelength was set to 265 nm to obtain maximum sensitivity for quantitation of triprolidine since it is present in small 
amount in the product; pseudoephedrine and dextromethorphan were also monitored at this wavelength. 20µl were 
injection volumes were used throughout the experimental work.  
2.3.6 Validation 
The optimized method was validated in according to the ICH guideline [35], the method linearity in the relevant working 
ranges, precision, and accuracy were evaluated. System suitability parameters were also determined. 
3. RESULTS AND DISCUSSION 
3.1 Optimization Design and Analysis 
Before starting an optimization procedure, the curvature term was investigated using factorial design with center points 
investigates. ANOVA generated for 2
k
 factorial design showed that curvature is significant for all the responses (the 
resolution between each pair of adjacent analytes peaks ) since p-value was less than 0.05. This implies that quadratic 
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should be considered to model the separation process [36]. In order to obtain second order predictive model Box-Behnken 
design was employed [37]. The optimum composition of the mobile phase was determined with series of mobile phases 
containing water: methanol mixtrues in the range of (45 - 50% v/v) containing ammonium acetate (35 - 45 mM/ L) with the 
pH being varied between 5-6. 
Derringer’s desirability function was used to optimize this process since the process involves optimization of three 
responses at a time [38].
 
 The resolutions between adjacent peak pairs were the responses considered for the purpose of 
optimization. The use of response surface methodologies (Figure 2)
 
indicated that the optimum mobile phase composition 
was 50% v/v methanol-water mixture having ionic strength 35.07 mM/ L
 
and pH 5.58. 
 
Fig 2: Graphical representation of  overall desirability function D ( =1.0) were pH (A) of 5.58 , methanol-water (B) of 
50% v/v, and ionic strength (C) of 35.07 mM/ L
 
Figure 3 shows a representative chromatogram of the optimization standard, standard solution, and real sample under the 
optimized conditions, where baseline separation of the relevant analytes was achieved within a reasonable time. 
The elution order of the analytes from the column was PS , DX and TR respectively; this order of elution can be related to 
their acid dissociation constants (pka) since  PS (pka = 9.8) , DX (pka = 8.3) and TR (pka = 6.5) [39]. PS being the storgest 
base among the three compounds was eluted first, followed by DX and TR respectively, under the optimized experimental 
conditions. This finding is consistent with the earlier observation [40], that if two bases are fully protonated then the 
stronger base is eluted before (has less affinity for the stationary phase) than the weaker one. 
Based on this finding it is possible to predict the elution order of basic compounds in a mixture  under cation exchange 
conditions  through the knowdeldge of their pka value , moreover this property can be used to adjust selectivity by proper 
selection of the mobile phase pH and manipulating its ionic strength and aqueous/organic ratio . 
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Fig 3: Chromatograms corresponding to a) optimization standard , b) standard   solution , c)   real sample (Unifed 
Syrup) , under optimum conditions (methanol-water = 50 % v/v, ionic strength = 35.07 mM/ L , and pH= 5.58) 
3.2 Method Validation 
The optimized method was validated in agreement with the ICH guideline [35]. Accordingly, method linearity in the 
relevant working ranges, precision and accuracy were evaluated. System suitability was also determined. 
3.2.1 Range and Linearity 
Method range and linearity were evaluated with six mixtures of standards at the following concentrations: 188.0 -1880.0 
µg/ml PSE, 61.3 - 613.0 µg/ml DX, and 8.60 - 86.0 µg/ml of TR, covering up to 125% of the expected concentration of the 
analytes in the formulation. Samples were injected in triplicate and calibrations were obtained by plotting the standard drug 
concentrations versus peak areas of the individual drugs. The calibration curves were defined by the equations shown in 
Table 1, and the residuals were spread uniformly and at random around the regression lines, passing the normality 
distribution test (p<0.05). In addition, correlation coefficients were higher than 0.99 and the confidence intervals of the 
intercepts contained the zero, confirming method linearity. 
3.2.2 Precision 
Method precision was verified in its repeatability and intermediate precision aspects according to the ICH guideline Q2 
(R1) [35]. Six replicate determinations of the samples containing 100%of their corresponding expected concentrations in 
the pharmaceutical product were injected and the relative standard deviation (RSD) of their recoveries was determined. 
The observed RSD levels (Table 1), which were below 2%, were considered satisfactory. For verification of the 
intermediate precision the process was repeated on another day using fresh reagents and samples, the samples were 
injected at random during two different days. This evidenced that the outcome of the determination was statistically similar 
regardless the day of the assay and the reagents preparation in the determinations. In addition, in all cases almost 
quantitative and consistent (RSD<2%) drug recoveries were recorded [41]. These results confirmed that the method is 
precise.  
Table 1: Results of Method validation 
Parameter PSE DX TR 
Number of calibration standards 6 6 6 
Concentration range (µg/ml) 188.0 -1880.0 61.3- 613.0 8.60–86.0 
Linearity – Regression equation  
Slope (b) 629.33 2465.57 25805.59 
Intercept (a) 9627.69 12200.08 9981.27 
Correlation coefficient (r
2
) 0.9998 0.9998 0.9996 
Standard deviation of the slope (sb) 6.59 24.23 267.13 
Standard deviation of the intercept (sa) 7527.72 9014.96 13960.82 
Precision 
Repeatability (recovery % ±SD)
 a
 98.46 ± 0.83 100.27 ± 0.64 104.10 ± 1.04 
Intermediate precision (recovery % ±SD)
 a
 98.62 ± 0.85 100.10 ± 0.64 103.79 ± 0.54 
Overall  analyte recovery %  (±SD) 98.54 ± 0.82 100.19 ± 0.62 103.95 ± 0.78 
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Accuracy (recovery % ±SD)
 b
 101.46 ± 0.51 98.72 ± 0.32 104.01 ± 0.61 
Limit of detection (µg/ml) 50.73 15.51 2.27 
Limit of quantitation (µg/ml) 153.72 46.99 6.88 
a  
Six replicates of sample at 100% level. 
b 
Triplicate injections of three independent sets of samples at six levels. 
3.2.3 Accuracy 
Method accuracy was demonstrated using standard addition method by evaluating analyte recoveries from a pre-assayed 
pharmaceutical formulation sample, containing 60% of the declared amounts of the drugs, which was fortified with known 
amounts of the three analytes, to reach concentration levels of 60% -120% of the expected drug concentrations in the 
pharmaceutical dosage form. The observed RSD levels (Table 1), which were below 2%, were considered satisfactory. 
This confirmed that the method enables the accurate determination of the analytes [41]. 
3.2.4 Limits of Detection LOD and Quantification LOQ 
In order to assess that the validated concentration ranges of the analytes were above their LOQ values, the LOD and LOQ 
were determined employing the ICH method based on the calibration curve [35]. The LOD values were 50.73 µg/ml for 
PSE, 15.51 µg/ml for DX, and 2.27 µg/ml for TR; the corresponding LOQ values, determined by the use of the same 
method, were 153.72, 46.99, and 6.88 µg/ml, respectively. These values fall below the lowest expected analyte 
concentrations in the samples. 
3.2.5 System Suitability Parameters 
System suitability parameters must be checked to ensure that the system is working correctly during the analysis. The test 
was carried out by injecting five replicates of the optimization standard. The method performance data including column 
efficiencies (N), resolutions between adjacent peeks (Rs), and asymmetry factor (As) are listed in Table 2. All the 
parameters were in good agreements with the theoretically required ones [42]. 
Table 2: System Suitability Parameters from Optimization Mixture Analysis 
Analyte Resolution (Rs) Asymmetry factor (As) Theoretical plates (N) 
PS 5.33 ± 0.2* 1.09 3670.8 
DX 3.77 ± 0.3 ** 1.16 3383.2 
TR 2.38 ± 0.4 ** 1.21 3314.8 
* resolution between PP and PS         ** resolution between PS and DX   
*** resolution between DX  and TR 
4. CONCLUSION 
A reliable and rapid liquid chromatography method for the simultaneous determination of PSE, DX, and PSE in syrup has 
been developed and validated. Experimental designs were employed for rational method optimization and demonstration 
of its suitability for the intended purpose. The use of strong cation exchange column enabled separation of the active 
principles within 10 min, despite their widely different properties; using very simple, relatively cheap and easy to prepare 
mobile phase. It was also possible to achieve their quantification in spite of the important abundance differences among 
the analytes (PSE: TR up to 24:1, w/w). In addition, the results indicate that the method is sensitive, linear, precise, and 
accurate, with regards to the mixture under investigation. Therefore, the method can be safely applied to the quality 
control of combined cough and cold medicines containing PSE, DX, and TR. 
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